| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5733782 | Journal of Surgical Research | 2017 | 7 Pages |
Abstract
ASA class 4, major morbidity, and likely dependent functional status are independent predictors of FTR following CRS/HIPEC to treat peritoneal carcinomatosis. Therefore, ASA class 4 and dependent functional status should be considered as contraindications for CRS/HIPEC and only offered in highly selective cases.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kevin Y. BS, Ali A. MD, MS, Rebecca M. MD, John C. MD, Michael A. MD, MBA, Mathew M. MD, PhD, Patricio M. MD,